Income StatementBalance SheetCash FlowSegments
Synopsys logo

Synopsys Cash Flow Statement

Operating, investing, and financing cash movements

Synopsys generated $2.4B in operating cash flow over the trailing twelve months. After $164.1M in capital expenditures, free cash flow was $2.3B. Free cash flow increased 0.8% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.4BNet Cash From Investing (TTM)-$16.5BNet Cash From Financing (TTM)$12.8BCapital Expenditures (TTM)$164.1MDepreciation And Amortization Cf (TTM)$1.1BNet Change In Cash (TTM)$672.7M
Latest FilingQ1 2026
Report Date2026-02-25
Market Cap$100.52B
P/E Ratio91.26
ROE5.53%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Other non-cash income (expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Change in accounts payable$170.0M-$313.7M—$273.9M-$44.9M-$37.3M
Change in accounts receivable$162.6M-$30.9M$105.0M—$146.2M$128.7M
Change in deferred revenue$54.9M-$97.0M——$255.2M$265.1M
Change in income taxes payable/receivable—$87.0M-$123.9M-$103.5M$146.7M$17.6M
Change in inventories—$55.9M———$29.4M
Change in other assets$31.1M$43.5M$0.0$391.7M$53.6M$81.4M
Benefit from Receivables$5.0M$9.9M$6.0M$7.6M$27.3M$8.2M
Deferred income taxes-$130.8M-$139.1M-$98.1M-$89.4M-$144.1M-$51.8M
Depreciation and amortization$114.9M$47.9M$48.9M$114.5M$449.1M$450.7M
Other Non-Cash Income (Expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Other Non-cash Income (Expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Other Non-cash Income (Expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Net cash from operating activities$562.8M-$67.5M$275.4M$671.0M$639.7M$856.8M
Net income$1.1B$297.4M$345.1M$242.3M$448.5M$64.7M
Other non-cash income (expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Amortization of capitalized costs to obtain revenue contracts$16.5M$12.5M$12.9M$13.5M$14.3M$19.3M
Amortization expense related to capitalized debt issuance costs$15.2M$10.5M————
Increase (Decrease) in Prepaid Expense and Other Assets$59.8M$103.6M$36.9M-$260.8M—-$84.6M
Increase (Decrease) in Operating Lease Liabilities-$169.2M$23.1M$25.5M$29.7M-$192.0M$32.3M
Other Noncash Income (Expense)-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Accounts Receivable, Credit Loss Expense (Reversal)$5.0M$9.9M$6.0M$7.6M$27.3M$8.2M
Reduction of Operating Lease Right-of-Use Assets$25.1M$25.5M$26.3M$29.1M$36.5M$36.4M
Gain (loss) on mark-to-market of Escrowed Shares$0.0$30.4M$30.4M$30.4M$30.4M—
Other Non-cash Income and Expense-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Other Non-Cash Adjustments-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Other Non-Cash Income and Expense-$4.3M-$186.0K$367.0K$556.0K$151.0K$218.0K
Stock-based compensation$152.3M$186.5M$201.7M$267.7M$237.4M$258.7M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures incurred but not yet paid$8.0M$6.1M$6.1M$6.1M$6.1M—
Debt Conversion Instrument Amount$0.0$0.0$0.0$0.0$0.0—
Income taxes paid$170.0M$128.2M$128.2M$128.2M$128.2M—
Non-cash divestiture consideration$5.6M$0.0$0.0$0.0$0.0—
Interest paid$203.5K$88.4M$88.4M$88.4M$88.4M—
Capital expenditures incurred but not yet paid$8.0M$6.1M$6.1M$6.1M$6.1M—
Capital Expenditures Incurred but Not Yet Paid$8.0M$6.1M$6.1M$6.1M$6.1M—

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$20.7M$40.7M$55.6M$38.6M$34.5M$35.3M
Payment for (Proceeds from) Other Investing Activity$0.0$611.0K———$0.0
Payments to Acquire Other Investments$53.0K$3.3M$80.0K$718.0K$14.0K$401.0K
Payments to Acquire Short-Term Investments$39.6M$37.3M$10.3M$0.0$18.2M$4.5M
Divestiture of businesses, net of cash transferred$1.4B$23.8M$46.3M$72.5M$604.0M$0.0
Proceeds from Maturities, Prepayments and Calls of Short-Term Investments$28.4M$19.7M$15.8M$18.2M$4.4M$3.7M
Proceeds From Sale Of Short Term Investments$12.1M$16.4M$5.6M$126.8M$8.4M$0.0
Net cash from investing activities$1.4B-$22.0M$76.0M-$16.5B$0.0-$36.5M
Proceeds from divestiture of prepaid business$1.4B$23.8M$46.3M$72.5M$604.0M$0.0

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Payments to Noncontrolling Interests$0.0$30.0M———$0.0
Common stock issuance for private placement—$0.0———$2.0B
Repayments of Debt—$1.3M$0.0$1.3M$861.1M$3.5B
Net cash from financing activities—-$141.8M$10.1B$4.2B$0.0-$1.6B
Proceeds from issuance of common stock$89.1M$14.4M$103.9M$19.8M$90.3M$12.7M
Taxes paid for net share settlement$59.0M$125.0M$41.9M$75.9M$62.7M$144.6M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$542.1M-$108.2M$219.8M$632.4M$605.2M$821.5M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash$3.3M-$9.7M$17.9M$463.0K—$3.4M
Net increase (decrease) in cash$2.0B-$240.9M$10.5B-$11.6B—-$759.4M
Accrued payables for capital expenditures$8.0M$6.1M$6.1M$6.1M$6.1M—
Fair value of replacement equity awards in connection with the acquisition of Ansys$0.0$32.7M$32.7M$32.7M$32.7M—
Issuance of common stock for the acquisition of Ansys$0.0$4.3B$4.3B$4.3B$4.3B—